Cargando…
Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension
BACKGROUND: Growth differentiation factor-15 (GDF-15) may be a biomarker of disease, protective response and/or prognosis, in older people with hypertension. AIMS: To correlate baseline GDF-15 levels with physical and vascular health data in this population. METHODS: Baseline blood samples were anal...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589783/ https://www.ncbi.nlm.nih.gov/pubmed/27734214 http://dx.doi.org/10.1007/s40520-016-0636-0 |
_version_ | 1783262404328554496 |
---|---|
author | Barma, Maryam Khan, Faisel Price, Rosemary J. G. Donnan, Peter T. Messow, C. Martina Ford, Ian McConnachie, Alex Struthers, Allan D. McMurdo, Marion E. T. Witham, Miles D. |
author_facet | Barma, Maryam Khan, Faisel Price, Rosemary J. G. Donnan, Peter T. Messow, C. Martina Ford, Ian McConnachie, Alex Struthers, Allan D. McMurdo, Marion E. T. Witham, Miles D. |
author_sort | Barma, Maryam |
collection | PubMed |
description | BACKGROUND: Growth differentiation factor-15 (GDF-15) may be a biomarker of disease, protective response and/or prognosis, in older people with hypertension. AIMS: To correlate baseline GDF-15 levels with physical and vascular health data in this population. METHODS: Baseline blood samples were analysed using a GDF-15 ELISA assay kit. Correlations with baseline and 12-month outcome data, including measures of physical and vascular function, were performed. RESULTS: A total of 147 individuals, mean age 76.8 ± 4.7 years, were included. 77 (52 %) were male. Baseline log(10)GDF-15 showed significant correlations with age (r = 0.37, p < 0.001), total cholesterol (r = −0.33, p < 0.001) and 6-min walking distance (r = −0.37, p < 0.001). Age remained significantly associated with log(10)GDF-15 in multivariable analysis (beta = −0.29, p = 0.001). Baseline log(10)GDF-15 was significantly associated with decline in 6-min walk distance over 12 months (beta = −0.27, p = 0.01) in multivariable models. No significant correlations were seen with changes in vascular function over 12 months. CONCLUSION: Baseline GDF-15 predicts declining physical, but not vascular, function in our population. |
format | Online Article Text |
id | pubmed-5589783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-55897832017-09-22 Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension Barma, Maryam Khan, Faisel Price, Rosemary J. G. Donnan, Peter T. Messow, C. Martina Ford, Ian McConnachie, Alex Struthers, Allan D. McMurdo, Marion E. T. Witham, Miles D. Aging Clin Exp Res Short Communication BACKGROUND: Growth differentiation factor-15 (GDF-15) may be a biomarker of disease, protective response and/or prognosis, in older people with hypertension. AIMS: To correlate baseline GDF-15 levels with physical and vascular health data in this population. METHODS: Baseline blood samples were analysed using a GDF-15 ELISA assay kit. Correlations with baseline and 12-month outcome data, including measures of physical and vascular function, were performed. RESULTS: A total of 147 individuals, mean age 76.8 ± 4.7 years, were included. 77 (52 %) were male. Baseline log(10)GDF-15 showed significant correlations with age (r = 0.37, p < 0.001), total cholesterol (r = −0.33, p < 0.001) and 6-min walking distance (r = −0.37, p < 0.001). Age remained significantly associated with log(10)GDF-15 in multivariable analysis (beta = −0.29, p = 0.001). Baseline log(10)GDF-15 was significantly associated with decline in 6-min walk distance over 12 months (beta = −0.27, p = 0.01) in multivariable models. No significant correlations were seen with changes in vascular function over 12 months. CONCLUSION: Baseline GDF-15 predicts declining physical, but not vascular, function in our population. Springer International Publishing 2016-10-12 2017 /pmc/articles/PMC5589783/ /pubmed/27734214 http://dx.doi.org/10.1007/s40520-016-0636-0 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Short Communication Barma, Maryam Khan, Faisel Price, Rosemary J. G. Donnan, Peter T. Messow, C. Martina Ford, Ian McConnachie, Alex Struthers, Allan D. McMurdo, Marion E. T. Witham, Miles D. Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension |
title | Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension |
title_full | Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension |
title_fullStr | Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension |
title_full_unstemmed | Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension |
title_short | Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension |
title_sort | association between gdf-15 levels and changes in vascular and physical function in older patients with hypertension |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589783/ https://www.ncbi.nlm.nih.gov/pubmed/27734214 http://dx.doi.org/10.1007/s40520-016-0636-0 |
work_keys_str_mv | AT barmamaryam associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension AT khanfaisel associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension AT pricerosemaryjg associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension AT donnanpetert associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension AT messowcmartina associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension AT fordian associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension AT mcconnachiealex associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension AT struthersalland associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension AT mcmurdomarionet associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension AT withammilesd associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension |